LFST vs. HIMS, GH, OPCH, RDNT, SHC, BTSG, SGRY, VCYT, CON, and PRVA
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Veracyte (VCYT), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.
LifeStance Health Group vs.
LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.
Hims & Hers Health has lower revenue, but higher earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
LifeStance Health Group presently has a consensus price target of $8.70, indicating a potential upside of 9.57%. Hims & Hers Health has a consensus price target of $25.13, indicating a potential downside of 42.31%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, research analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.
LifeStance Health Group has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500.
Hims & Hers Health received 30 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 39.05% of users gave Hims & Hers Health an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote.
In the previous week, Hims & Hers Health had 38 more articles in the media than LifeStance Health Group. MarketBeat recorded 41 mentions for Hims & Hers Health and 3 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.22 beat Hims & Hers Health's score of 0.67 indicating that LifeStance Health Group is being referred to more favorably in the media.
Summary
Hims & Hers Health beats LifeStance Health Group on 13 of the 18 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LifeStance Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:LFST) was last updated on 2/12/2025 by MarketBeat.com Staff